Anthony ESTRADA,Alan G. OLIVERO,Snahel PATEL,Michael SIU,Joseph LYSSIKATOS
申请号：
US16568130
公开号：
US20200171029A1
申请日:
2019.09.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.
